Sudarshan Pharma Industries board meeting scheduled for May 15, 2026 to consider FCCB issuance.
Proposal follows shareholder approval on August 11, 2025 and BSE in-principle approval on September 26, 2025.
FCCB issuance subject to receipt of applicable regulatory and statutory approvals.